1. Mattison DR, Malek A, Cistola C. Physiologic adaptations to pregnancy: Impact on pharmacokinetics. In: Yaffe-Aranda, ed. Pediatric Pharmacology, Therapeutic Principles in Practice (2nd edition). Philadelphia: WB Saunders Company; 1993. p. 81–96.
2. Changes in enoxaparin kinetics on anti-Xa activity during pregnancy and implications for antithrombotic therapeutic strategy;Lebaudy;Clin Pharmacol Ther,2008
3. Kaufmann P, Schellen I. Placental development. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: Saunders; 1992. p. 47–56.
4. Placental transfer of drugs administered to the mother;Pacifici;Clin Pharmacokinet,1995
5. The ABC trans porter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction;Evseenko;FASEB J,2007